Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: Jazzy Jeff who wrote (16620)	5/12/1998 9:30:00 AM
From: Don Powrie	Respond to of 34592

>>>>NEWS! NASDAQ: BPRX (An earlier TokyoMex pick...)(One that I made some money on!! Thanks TM) Company Press Release BRADLEY PHARMACEUTICALS Announces the Introduction of LUBRIN Lubricating 2-Pack in Response to Increased Sexual Interest Generated by VIAGRA FAIRFIELD, N.J.--(BW HealthWire)--May 12, 1998--BRADLEY PHARMACEUTICALS, INC. (NASDAQ NMS: BPRX - news) announced today that LUBRIN(R) Lubricating 2-Pack, consisting of newly-introduced LUBRIN(R) Lubricating Liquid, available in a 2 oz. bottle, paired with a box of traditional, patented, LUBRIN(R) Vaginal Inserts, is scheduled to be introduced in the Second Quarter 1998. LUBRIN(R) Vaginal Inserts will continue to be positioned as a primary product for women and LUBRIN(R) Lubricating Liquid will be positioned as a personal lubricant applied by either sexual partner. Research & development has been completed on LUBRIN(R) Lubricating Liquid for several months. However, in response to the extraordinary demand for personal lubricants sparked by the unprecedented acceptance of VIAGRA(R) (Registered trademark of Pfizer, Inc. NYSE: PFE), the LUBRIN(R) Lubricating Liquid marketing launch introduction date has been moved closer. An estimated 14 million, predominantly older, men are now looking forward to renewed sexual activity thus effecting increased renewal of sexual activity in their often post-menopausal partners. Chairman and Chief Executive Officer, Daniel Glassman, stated, ''LUBRIN(R) Vaginal Insert sales have been growing steadily for the past several years because LUBRIN(R) Vaginal Inserts provide fast and prolonged lubrication for vaginal dryness. Recommended by Obstetricians and Gynecologists, it is a proven, safe and reliable form of personal lubrication. In keeping with the Company's corporate strategy of enhancing & growing existing product lines through the introduction of line extension products and increased marketing, we planned to introduce a liquid form of LUBRIN(R) in the future. With the impact of VIAGRA(R) affecting noticeable increases in LUBRIN (R) Vaginal Inserts sales, the timetable has been moved up for the introduction of this important line extension liquid product which can be applied by men as well as women. We plan to significantly increase the promotion of LUBRIN(R) to physician audiences, specifically OB-GYN's, pharmacists and directly to consumers.'' LUBRIN(R) Lubricating Liquid introduction in a 2-pack with LUBRIN(R) Vaginal Inserts will be the only personal lubricating dual pack on the market and is representative of the major activity of the Company in 1998. In addition to LUBRIN(R), the Company is gearing up to introduce ENTsol(TM) Nasal Lavage System in September. And, with the successful introduction of LE PONT(TM) BEAUTY ENHANCER Vitamin C Dermal Patch to reduce the appearance of wrinkles, which is making substantial monthly gains in national distribution and sales, the Company is moving forward with Vitamin-C based line extensions that will begin with a Le Pont(TM) Vitamin C facial serum. This is a very exciting phase in our Company's history, one that we believe will realize significant profits.'' BRADLEY PHARMACEUTICALS, INC. manufactures and markets brandname prescription and over-the-counter pharmaceuticals and health-related products throughout the United States as well as in twenty-seven international markets. Please visit our website at www.bradpharm.com